Exploratory clinical and functional associations of OTUD7B expression in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is clinically heterogeneous, and biomarkers that improve assessment of treatment response and prognosis remain needed. To examine the clinical and functional associations of OTUD7B expression in DLBCL in an exploratory single-center study. OTUD7B expression was assessed by immunohistochemistry in 103 DLBCL specimens using a 20% tumor-cell positivity cutoff. Associations with response and survival were evaluated using contingency analyses, Kaplan-Meier methods, and Cox regression. OTUD7B was silenced in SU-DHL-4 and U-2932 cells with a selected lentiviral shRNA after screening three constructs. Relative cell viability, apoptosis, and cell-cycle distribution were assessed. TCGA-DLBC RNA-sequencing data were analyzed for exploratory molecular associations. Seventy-seven tumors were classified as OTUD7B-high and 26 as OTUD7B-low. Objective response occurred in 62 of 77 patients (80.5%) in the high-expression group and 10 of 26 (38.5%) in the low-expression group ( P < 0.001). High expression was associated with longer overall survival by log-rank analysis ( P = 0.021), but OTUD7B was not independently associated with overall or progression-free survival in the fully adjusted models. OTUD7B knockdown increased basal CCK-8 signal and reduced apoptosis; however, drug-exposure viability effects were inconsistent across cell lines and were mostly nonsignificant. Transcriptomic enrichment results were associative and were not supported by direct pathway or metabolic assays. OTUD7B expression was associated with treatment response and unadjusted overall survival in this cohort. The functional findings support hypothesis generation but do not establish OTUD7B as an independent prognostic biomarker or a mechanistic determinant of drug resistance. Independent clinical validation and orthogonal functional studies are required.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Medicine
Published
2026-11-21
DOI
https://doi.org/10.1007/s10238-026-02393-z
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploratory clinical and functional associations of OTUD7B expression in diffuse large B-cell lymphoma

Xianglu Zhu, Mei Wu, Shujuan Wen, Shan Li et al.
Clinical and Experimental Medicine
Lymphoma Diagnosis and Treatment
article

Exploratory clinical and functional associations of OTUD7B expression in diffuse large B-cell lymphoma

Xianglu Zhu, Mei Wu, Shujuan Wen, Shan Li, Lin Zhu
article en

Abstract

Diffuse large B-cell lymphoma (DLBCL) is clinically heterogeneous, and biomarkers that improve assessment of treatment response and prognosis remain needed. To examine the clinical and functional associations of OTUD7B expression in DLBCL in an exploratory single-center study. OTUD7B expression was assessed by immunohistochemistry in 103 DLBCL specimens using a 20% tumor-cell positivity cutoff. Associations with response and survival were evaluated using contingency analyses, Kaplan-Meier methods, and Cox regression. OTUD7B was silenced in SU-DHL-4 and U-2932 cells with a selected lentiviral shRNA after screening three constructs. Relative cell viability, apoptosis, and cell-cycle distribution were assessed. TCGA-DLBC RNA-sequencing data were analyzed for exploratory molecular associations. Seventy-seven tumors were classified as OTUD7B-high and 26 as OTUD7B-low. Objective response occurred in 62 of 77 patients (80.5%) in the high-expression group and 10 of 26 (38.5%) in the low-expression group ( P < 0.001). High expression was associated with longer overall survival by log-rank analysis ( P = 0.021), but OTUD7B was not independently associated with overall or progression-free survival in the fully adjusted models. OTUD7B knockdown increased basal CCK-8 signal and reduced apoptosis; however, drug-exposure viability effects were inconsistent across cell lines and were mostly nonsignificant. Transcriptomic enrichment results were associative and were not supported by direct pathway or metabolic assays. OTUD7B expression was associated with treatment response and unadjusted overall survival in this cohort. The functional findings support hypothesis generation but do not establish OTUD7B as an independent prognostic biomarker or a mechanistic determinant of drug resistance. Independent clinical validation and orthogonal functional studies are required.

Clinical and Experimental Medicine
Tumor Hospital of Xinjiang Medical University (CN)
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Exploratory clinical and functional associations of OTUD7B expression in diffuse large B-cell lymphoma — Xianglu Zhu, Mei Wu, et al. · Clinical and Experimental Medicine (2026) | TGRS Research Map | TGRS